Published in Circ Cardiovasc Genet on December 01, 2009
Genetic and ElectroNic medIcal records to predict oUtcomeS in Heart Failure patients (GENIUS-HF) - design and rationale. BMC Cardiovasc Disord (2014) 0.80
Resolving the etiology of atopic disorders by using genetic analysis of racial ancestry. J Allergy Clin Immunol (2016) 0.75
Genetically determined ancestry is more informative than self-reported race in HIV-infected and -exposed children. Medicine (Baltimore) (2016) 0.75
Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension (2005) 3.07
Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation (2005) 2.47
Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. J Am Coll Cardiol (2004) 2.17
Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload. Hypertension (2007) 2.17
Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction. Circ Heart Fail (2011) 2.01
High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circ Heart Fail (2010) 1.96
Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study. Hum Mol Genet (2011) 1.77
Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J (2010) 1.55
Third heart sound and elevated jugular venous pressure as markers of the subsequent development of heart failure in patients with asymptomatic left ventricular dysfunction. Am J Med (2003) 1.51
Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity. Circ Res (2008) 1.49
Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy. Circ Heart Fail (2009) 1.12
Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction. Am J Cardiol (2004) 1.00
Genomics, transcriptional profiling, and heart failure. J Am Coll Cardiol (2009) 0.98
Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol (2002) 0.92
The prognostic value of the physical examination in patients with chronic heart failure. Congest Heart Fail (2003) 0.89
Process matters: Emerging concepts underlying impaired natriuretic peptide system function in heart failure. Circ Heart Fail (2011) 0.88
Genome-wide association study of cardiac structure and systolic function in African Americans: the Candidate Gene Association Resource (CARe) study. Circ Cardiovasc Genet (2012) 0.87
Potential contributing factors to noncompliance with dietary sodium restriction in patients with heart failure. Am Heart J (2002) 0.87
Heart failure and cardiac hypertrophy. Curr Treat Options Cardiovasc Med (2007) 0.86
Systolic time ratio by impedance cardiography to distinguish preserved vs impaired left ventricular systolic function in heart failure. Congest Heart Fail (2008) 0.85
Blacks and whites have a similar prevalence of reduced left ventricular ejection fraction in the general population: the Dallas Heart Study (DHS). Am Heart J (2008) 0.84
Relevance of molecular forms of brain natriuretic peptide for natriuretic peptide research. Hypertension (2007) 0.79
Regulated inositol-requiring protein 1-dependent decay as a mechanism of corin RNA and protein deficiency in advanced human systolic heart failure. J Am Heart Assoc (2014) 0.78
Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation. J Heart Lung Transplant (2005) 0.77
The prognostic significance of renal dysfunction in patients with chronic systolic heart failure. Curr Cardiol Rep (2003) 0.76
Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte. J Mol Cell Cardiol (2011) 0.76
Profound hyperacute cardiac allograft rejection rescue with biventricular mechanical circulatory support and plasmapheresis, intravenous immunoglobulin, and rituximab therapy. J Cardiothorac Surg (2013) 0.75
Postexercise severe ventricular ectopy in heart failure patients: new marker for aggregate risk. J Am Coll Cardiol (2004) 0.75
Beta-blocker therapy in patients with heart failure in the urban setting: moving beyond clinical trials. Am Heart J (2004) 0.75
Relation of lower hematocrit to progression from asymptomatic left ventricular dysfunction to symptomatic heart failure (from the Studies of Left Ventricular Dysfunction Prevention trial). Am J Cardiol (2005) 0.75